Bears take control on Nifty Pharma; Sun Pharma sinks 3%, Divis Lab struggles as well

Cipla was 0.56% down while Lupin trades 0.44% lower. DR Reddy and Auro Pharma were marginally lower.

February 12, 2021 1:30 IST India Infoline News Service

Nifty Pharma stocks were bearish during Friday’s trade. Sun Pharma dragged the index most by shedding 2%. Divis Lab, Cipla, Lupin and DR Reddys also struggled.

At around 1.30 pm, Nifty Pharma was trading at 12,830.25 down 99.55 points or 0.77%, touching a high of 13,013.75 and low of 12,822.10 on Friday.

Sun Pharmaceutical Industries traded 2.45% lower at Rs627.90 per piece, despite settlement of case with SEBI for alleged fund diversion by paying a total amount of Rs1.55cr as charges.

Divis Lab shed 0.85% to trade at Rs3,721.85 per piece. Cipla was 0.56% down while Lupin trades 0.44% lower. DR Reddy and Auro Pharma were marginally lower.

Torrent Pharma, Cadila and Biocon gave the sector little support with marginal gains. Biocon was 0.23% higher, Torrent Pharma gained 0.47% while Cadila was higher 0.24%. 

Biocon Biologics Ltd., a subsidiary of Bengaluru-headquartered Biocon Ltd., has announced that Kixelle, a biosimilar insulin as part co-developed with NASDAQ-listed Viatris Inc., has received marketing authorisation approval from the European Commission. 

Nifty Pharma had 3 advances and 7 declines on Friday. 

Related Story

Get Access to Stock Reports+ and Customised Investment Ideas